Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longya Guanxinkang capsule for angina pectoris (Qi deficiency and blood stasis)
CTR20140032Phase 2Completed
- Sponsor
- Jilin Academy of Chinese Medicine Sciences
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Longya Guanxinkang in angina pectoris, coronary arteriosclerosis, sponsored by Jilin Academy of Chinese Medicine Sciences. Started Jun 2014; status: completed.
02
Drugs
Longya Guanxinkang
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20140032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140032.